These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 20870017)
1. Therapeutic potential of some stress mediators in early Alzheimer's disease. Pardon MC Exp Gerontol; 2011; 46(2-3):170-3. PubMed ID: 20870017 [TBL] [Abstract][Full Text] [Related]
2. Amyloid-beta, tau, and dementia. Takashima A J Alzheimers Dis; 2009; 17(4):729-36. PubMed ID: 19542626 [TBL] [Abstract][Full Text] [Related]
3. Plaques, tangles, and memory loss in mouse models of neurodegeneration. Eriksen JL; Janus CG Behav Genet; 2007 Jan; 37(1):79-100. PubMed ID: 17072762 [TBL] [Abstract][Full Text] [Related]
4. [Therapy of Alzheimer disease]. Kovács T Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816 [TBL] [Abstract][Full Text] [Related]
5. [Significance of tau in the development of Alzheimer's disease]. Takashima A Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874 [TBL] [Abstract][Full Text] [Related]
7. The modulation of metal bio-availability as a therapeutic strategy for the treatment of Alzheimer's disease. Crouch PJ; White AR; Bush AI FEBS J; 2007 Aug; 274(15):3775-83. PubMed ID: 17617225 [TBL] [Abstract][Full Text] [Related]
8. [Involvement of beta-amyloid in the etiology of Alzheimer's disease]. Tomiyama T Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873 [TBL] [Abstract][Full Text] [Related]
9. [Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?]. Buée L; Blum D; Bombois S; Buée-Scherrer V; Caillet-Boudin ML; Colin M; Deramecourt V; Dhaenens CM; Galas MC; Hamdane M; Humez S; Maurage CA; Pasquier F; Sablonnière B; Schraen-Maschke S; Sergeant N Therapie; 2010; 65(5):401-7. PubMed ID: 21144474 [TBL] [Abstract][Full Text] [Related]
10. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model. Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202 [TBL] [Abstract][Full Text] [Related]
11. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Frisardi V; Solfrizzi V; Seripa D; Capurso C; Santamato A; Sancarlo D; Vendemiale G; Pilotto A; Panza F Ageing Res Rev; 2010 Oct; 9(4):399-417. PubMed ID: 20444434 [TBL] [Abstract][Full Text] [Related]
12. [Perspectives on the amyloid cascade hypothesis of Alzheimer's disease]. Simón AM; Frechilla D; del Río J Rev Neurol; 2010 Jun; 50(11):667-75. PubMed ID: 20514639 [TBL] [Abstract][Full Text] [Related]
13. Olfactory tau pathology in Alzheimer disease and mild cognitive impairment. Attems J; Jellinger KA Clin Neuropathol; 2006; 25(6):265-71. PubMed ID: 17140156 [TBL] [Abstract][Full Text] [Related]
14. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging? Swerdlow RH Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913 [TBL] [Abstract][Full Text] [Related]
15. Disease modifying therapy for AD? Golde TE J Neurochem; 2006 Nov; 99(3):689-707. PubMed ID: 17076654 [TBL] [Abstract][Full Text] [Related]
18. The role of nicotinic acetylcholine receptors in Alzheimer's disease. Oddo S; LaFerla FM J Physiol Paris; 2006; 99(2-3):172-9. PubMed ID: 16448808 [TBL] [Abstract][Full Text] [Related]
19. [Treatment strategy of Alzheimer's disease: pause in clinical trials of Abeta vaccine and next steps]. Kuzuhara S Brain Nerve; 2010 Jul; 62(7):659-66. PubMed ID: 20675870 [TBL] [Abstract][Full Text] [Related]